undamentalytics Newsletter

Atricure, Inc. revenue

Atricure, Inc.'s revenue was $535m in fiscal 2025, up 14.9% on the year before. Since fiscal 2009 ($54.5m) it has grown at a compound 15.3% a year. Over the last twelve months it was $570m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Atricure, Inc.: revenue history, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue5559647082107130155175202231207274330399465535570
Growth on the year before—+8.2%+9.1%+9.1%+16.6%+31.2%+20.8%+19.5%+12.6%+15.4%+14.5%−10.5%+32.8%+20.4%+20.8%+16.5%+14.9%—
Gross profit42454750607693111126147170149206246300348401435

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $435M 81.4% ▲ 13.7%
Outside the US $99.2M 18.6% ▲ 20.2%
Europe (part of Outside the US) $61.5M 62.0% ▲ 23.3%
Asia Pacific (part of Outside the US) $30.7M 31.0% ▲ 12.2%
Other International (part of Outside the US) $6.9M 7.0% ▲ 32.5%

From Atricure, Inc.'s 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Atricure, Inc. $570m 13.9% 15.9%
Bioventus Inc. $586m 3.9% 5.2%
Transmedics Group, Inc. $668m 25.8% 64.2%
Artivion, Inc. $471m 16.4% 12.8%
Glaukos Corp $690m 46.9% 31.5%
Novocure Ltd $725m 12.9% 12.9%

Compare with peers

Head to head: ATRC vs BVSATRC vs TMDXAORT vs ATRC

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Atricure, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Atricure, Inc.